Drug search by name

Immune globulin intravenous and subcutaneous and Renal disease

Result of checking the interaction of drug Immune globulin intravenous and subcutaneous and disease Renal disease for safety when used together.

Check result:

Immune globulin intravenous and subcutaneous <> Renal disease

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Renal abnormalities such as acute tubular necrosis, proximal tubular nephropathy, osmotic nephrosis, including acute renal dysfunction/failure and death have been reported after immune globulin intravenous (IGIV) products. Cases of renal dysfunction and acute renal failure occur more commonly in patients receiving IGIV products containing sucrose as a stabilizer. Ensure that patients are not volume-depleted before administering these agents and assess renal function, including measurement of blood urea nitrogen (BUN) and serum creatinine, before initiating the infusion and at appropriate intervals thereafter. If renal function deteriorates, consider discontinuation of the product. Periodic monitoring of renal function and urine output is important in patients at increased risk of developing acute renal failure. Administer these agents at the minimum dose and rate of infusion practicable in patients at risk for renal dysfunction or failure.

Immune globulin intravenous and subcutaneous

Generic Name: immune globulin intravenous and subcutaneous

Brand Name: Gammagard, Gammaked, Gamunex-C, Gammagard Liquid

Synonyms: Immune globulin (intravenous and subcutaneous)

What is Immune globulin intravenous and subcutaneous?